Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212908934> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W3212908934 endingPage "2067" @default.
- W3212908934 startingPage "2067" @default.
- W3212908934 abstract "Abstract Background: Patients with heterozygous signal transducer and activator of transcription 1 (STAT1) gain-of-function (GOF) pathogenic variants exhibit an array of clinical phenotypes including susceptibility to multiple infections, autoimmunity, and cancer predisposition. Previous studies to characterize the pathways involved and explore therapeutic interventions have been constrained by the technology to perform in-depth immunophenotyping. Mass cytometry has allowed us to perform extensive immune profiling of patients with inborn errors of immunity (IEI) to help gain a better understanding of disease pathology. STAT1 gain-of-function (GOF) mutations have demonstrated higher levels of phosphorylated STAT1 in response to type I and II interferons, but the response to other cytokines is less understood. Using advanced cytometry, we demonstrate a unique pattern of STAT1 phosphorylation in response to IL-6 stimulation in T-cell subsets and this differential pattern may play a role in T-cell differentiation and memory in STAT1 GOF patients. Cases: We report two patients with heterozygous STAT1 GOF mutations in the coiled-coil domain. For both patients, the clinical phenotype was largely consistent with other STAT1 GOF patients, one (P1, c.800C>T; p.ala267Val) presented with secondary HLH due to histoplasmosis, and the second (P2, c.866A>G; p.Tyr289Cys) presented with presumed vaccine strain varicella zoster virus (VZV) meningitis and subsequent history of recurrent herpes simplex virus (HSV) skin lesions. Patient peripheral blood mononuclear cells (PBMCs) were evaluated by fluorescence flow cytometry and cytometry by time of flight (CyTOF) as previously described (Roussel et al. J Leukoc Biol. 2017) to evaluate the impact of STAT1 GOF mutations on T-cell immunophenotype and cytokine signaling. Results: Utilizing cytometric data, we were able to identify similar patterns of T cell distribution on t-distributed stochastic neighbor embedding (t-SNE) plots for both patients with STAT1 GOF that were distinct compared to healthy controls (Fig 1a). In the T-cell compartment, both patients had decreased Th17 and Treg populations and an increased Th1/Th2 ratio compared to healthy donor (Fig 1b). In response to stimulation with IFNg or IL-6, there were also clear patterns with the two patients compared to healthy controls. Levels of p-STAT1 and p-STAT3 were assessed in STAT1 GOF and health donor PBMCs at several times points between 15 and 120 minutes, after stimulation with either IFNg or IL-6. Using fluorescence flow, we found that IL-6 stimulation led to greater than anticipated p-STAT1 response at all timepoints compared to a much more muted response to IFNg. The cell subsets highlighted in the t-SNE after IL-6 stimulation differ from the cell subsets that respond to IFNg stimulation in patients and healthy control (Fig 2a), suggesting that distinct cell populations are driving the response to IL-6. By evaluating these IL-6 responsive subsets in comparison with healthy control by CyTOF, we identified an exaggerated p-STAT1 response to IL-6 in the memory T-cell populations in P2 (Fig 2b). Conclusions: These two unique clinical presentations demonstrate that with similar mutations in the coiled-coil domain of STAT1, yet largely differing clinical presentations, the immune profiling patterns of the patients compared to healthy controls can drive further work on disease characterization and therapeutic interventions. This is relevant for this patient cohort, as treatment recommendations for STAT1 GOF are not well established. Long-term outcomes with JAK inhibition are lacking and transplant survival rates to date have been very poor compared to other immune diseases including familial HLH. With identification of IL-6 signaling playing a potential role in T-cell maturation, further studies will need to be performed to determine if IL-6 modulation could be used as a treatment modality. We conclude that performing deep immunophenotyping of patients with inborn errors of immunity (IEIs) such as STAT1 GOF can point to new disease mechanisms of human immunity and inflammation and lead to improved understanding of the role of cytokine and cellular signaling in normal hematopoiesis and cellular maturation. Figure 1 Figure 1. Disclosures Rathmell: Sitryx: Consultancy, Current equity holder in publicly-traded company, Research Funding; Caribou: Consultancy, Current equity holder in publicly-traded company, Current holder of stock options in a privately-held company; Nirogy: Consultancy, Current holder of stock options in a privately-held company; Merck: Speakers Bureau; Pfizer: Speakers Bureau; Mitobridge: Consultancy; Incyte: Research Funding; Calithera: Research Funding; Tempest: Research Funding." @default.
- W3212908934 created "2021-11-22" @default.
- W3212908934 creator A5024772697 @default.
- W3212908934 creator A5044844090 @default.
- W3212908934 creator A5056373193 @default.
- W3212908934 creator A5067664170 @default.
- W3212908934 creator A5077678938 @default.
- W3212908934 creator A5085341464 @default.
- W3212908934 creator A5085486817 @default.
- W3212908934 date "2021-11-05" @default.
- W3212908934 modified "2023-09-28" @default.
- W3212908934 title "Deep Immune Profiling of Patients with <i>STAT1</i> Gain-of-Function: Revealing New Mechanisms of Pathology" @default.
- W3212908934 doi "https://doi.org/10.1182/blood-2021-151057" @default.
- W3212908934 hasPublicationYear "2021" @default.
- W3212908934 type Work @default.
- W3212908934 sameAs 3212908934 @default.
- W3212908934 citedByCount "2" @default.
- W3212908934 countsByYear W32129089342022 @default.
- W3212908934 countsByYear W32129089342023 @default.
- W3212908934 crossrefType "journal-article" @default.
- W3212908934 hasAuthorship W3212908934A5024772697 @default.
- W3212908934 hasAuthorship W3212908934A5044844090 @default.
- W3212908934 hasAuthorship W3212908934A5056373193 @default.
- W3212908934 hasAuthorship W3212908934A5067664170 @default.
- W3212908934 hasAuthorship W3212908934A5077678938 @default.
- W3212908934 hasAuthorship W3212908934A5085341464 @default.
- W3212908934 hasAuthorship W3212908934A5085486817 @default.
- W3212908934 hasBestOaLocation W32129089341 @default.
- W3212908934 hasConcept C137061746 @default.
- W3212908934 hasConcept C196166836 @default.
- W3212908934 hasConcept C202751555 @default.
- W3212908934 hasConcept C203014093 @default.
- W3212908934 hasConcept C2776178377 @default.
- W3212908934 hasConcept C2777003663 @default.
- W3212908934 hasConcept C2779727006 @default.
- W3212908934 hasConcept C54355233 @default.
- W3212908934 hasConcept C553184892 @default.
- W3212908934 hasConcept C71924100 @default.
- W3212908934 hasConcept C86803240 @default.
- W3212908934 hasConcept C8891405 @default.
- W3212908934 hasConceptScore W3212908934C137061746 @default.
- W3212908934 hasConceptScore W3212908934C196166836 @default.
- W3212908934 hasConceptScore W3212908934C202751555 @default.
- W3212908934 hasConceptScore W3212908934C203014093 @default.
- W3212908934 hasConceptScore W3212908934C2776178377 @default.
- W3212908934 hasConceptScore W3212908934C2777003663 @default.
- W3212908934 hasConceptScore W3212908934C2779727006 @default.
- W3212908934 hasConceptScore W3212908934C54355233 @default.
- W3212908934 hasConceptScore W3212908934C553184892 @default.
- W3212908934 hasConceptScore W3212908934C71924100 @default.
- W3212908934 hasConceptScore W3212908934C86803240 @default.
- W3212908934 hasConceptScore W3212908934C8891405 @default.
- W3212908934 hasIssue "Supplement 1" @default.
- W3212908934 hasLocation W32129089341 @default.
- W3212908934 hasOpenAccess W3212908934 @default.
- W3212908934 hasPrimaryLocation W32129089341 @default.
- W3212908934 hasRelatedWork W102419399 @default.
- W3212908934 hasRelatedWork W1518295571 @default.
- W3212908934 hasRelatedWork W1976657964 @default.
- W3212908934 hasRelatedWork W2340194919 @default.
- W3212908934 hasRelatedWork W2370565999 @default.
- W3212908934 hasRelatedWork W2373897826 @default.
- W3212908934 hasRelatedWork W2381126555 @default.
- W3212908934 hasRelatedWork W2381196212 @default.
- W3212908934 hasRelatedWork W2972647879 @default.
- W3212908934 hasRelatedWork W3005986839 @default.
- W3212908934 hasVolume "138" @default.
- W3212908934 isParatext "false" @default.
- W3212908934 isRetracted "false" @default.
- W3212908934 magId "3212908934" @default.
- W3212908934 workType "article" @default.